Anticonvulsants during pregnancy: a danger to the developing fetus?
D000014:Abnormalities, Drug-Induced / Q000453:epidemiology / Q000517:prevention & control; D000927:Anticonvulsants / Q000009:adverse effects*; D001463:Barbiturates / Q000009:adverse effects; D001778:Blood Coagulation Disorders / Q000139:chemically induced / Q000517:prevention & control; D002869:Chromosome Aberrations / Q000139:chemically induced; D025063:Chromosome Disorders; D005260:Female; D005333:Fetus / Q000187:drug effects*; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D010672:Phenytoin / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011324:Primidone / Q000009:adverse effects; D013388:Succinimides / Q000009:adverse effects; D014293:Trimethadione / Q000009:adverse effects; D014812:Vitamin K / Q000627:therapeutic use; D006475:Vitamin K Deficiency Bleeding / Q000139:chemically induced
D000927:Anticonvulsants; D001463:Barbiturates; D013388:Succinimides; D014812:Vitamin K; D011324:Primidone; D010672:Phenytoin; D005492:Folic Acid; D014293:Trimethadione